Gopakumar Nair
About Gopakumar Nair
Gopakumar Nair serves as the Senior Director of Toxicology at Supernus Pharmaceuticals, Inc., where he has worked since 2020. He has extensive experience in drug discovery and development, with a focus on nonclinical safety and toxicology.
Work at Supernus Pharmaceuticals
Gopakumar Nair has held multiple positions at Supernus Pharmaceuticals, Inc. since 2014. He currently serves as Senior Director of Toxicology, a role he has occupied since 2020. Prior to this, he was the Director of Toxicology from 2017 to 2020 and the Associate Director of Preclinical & Competitive Intelligence from 2014 to 2017. In these roles, he has contributed to the strategic planning and execution of IND-enabling programs and regulatory submissions, focusing on nonclinical safety development and toxicology.
Education and Expertise
Gopakumar Nair obtained his Master's Degree and completed residency training in Veterinary Anatomic Pathology at Purdue University from 2003 to 2006. He also earned a Bachelor of Veterinary Science (BVSc), equivalent to a Doctor of Veterinary Medicine (DVM), from Kerala Agricultural University between 1990 and 1995. His educational background supports his expertise in toxicology and nonclinical safety development for drug candidates.
Background
Before joining Supernus Pharmaceuticals, Gopakumar Nair worked at Hoffmann-La Roche as a Research Leader from 2009 to 2013 in Nutley, NJ. His career has been characterized by a focus on drug discovery and development, where he has accumulated broad experience in the field. His roles have involved significant responsibilities in toxicology and related studies.
Achievements
Gopakumar Nair serves as a subject matter expert in nonclinical safety development, particularly in toxicology. His extensive experience includes strategic planning and execution of IND-enabling programs and regulatory submissions. His contributions to the field of toxicology and drug development have been recognized within the industry.